At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 48 enrolled
Drug / intervention
delivery systemother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Representative Users Study Of Operating Characteristics Of The Caverject Delivery System.
In Brief
A Phase 3 clinical trial evaluating delivery system for Erectile Dysfunction. Completed, enrolled 48 participants across 2 sites.
Detailed Summary
The purpose of this study is to demonstrate the usability of the system.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsErectile Dysfunction
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 2009
Enrollment StartFeb 2011
Primary CompletionFeb 2011
TodayJul 2026
First PostedNov 6, 2009
Enrollment StartFeb 1, 2011
Primary CompletionFeb 1, 2011
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 16.7 years ago
Interventions
delivery systemother
syringe